Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


VaxInnate, Inc.

Latest From VaxInnate, Inc.

The Role Of Genomics In Future Of Medicine – The Personalis View

Personalis CEO John West, the former head of Solexa, talks about the clinical expansion plans he has for a company that currently already accounts for 4% of the global DNA and RNA sequencing.

Innovation Cellular & Genetic

New Trends In R&D Partnering: Biopharma’s Bet On The US Veterans Administration

The US Veterans Administration is attracting more interest from drugmakers seeking to grow their foothold in the lucrative – but scientifically challenging – market for CNS disorders. The allure comes from VA’s strong analytics and data crunching capabilities as well as its investigatory and trial management expertise in high-profile areas like traumatic brain injury, post-traumatic stress and major depression.

Innovation BioPharmaceutical

VaxInnate snags $53m under BARDA contract extension

US biotech VaxInnate is gaining an additional $53m under its February 2011 contract with the Biomedical Advanced Research and Development Authority (BARDA) to develop vaccines against influenza.

Infectious Diseases Neurology

Venture Funding Deals, December 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced October through November 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology